Epidemiological Features and Clinical Course of SARS-CoV-2 Infection in Cancer Patients Within the Veneto Oncology Network: the ROVID Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 761
- 试验地点
- 3
- 主要终点
- The rate of SAR-COV2 infection development in association with tumor characteristics.
研究概览
简要总结
The study aims to retrospectively collect epidemiological and clinical data in patients with solid tumors and SARS Covid2 infections belonging to oncology centers within the Veneto Oncology Network
详细描述
The aim of this study is to create a Veneto Oncology Network with the aim of collecting clinical and epidemiological data of cancer Patients affected by SAR- Covid-2 infection over a period of 1 year. Descriptive statistical approaches will be used to process the data.
The aim is to evaluate the development rate of severe clinical forms of infection in patients with SARS-Cov-2 and the possible association with tumour characteristics and treatment.
In addition, the results of serological tests can be compared with the outcome of the diagnostic swabs and the clinical evolution of the infection in order to obtain more information regarding the significance of specific antibody development.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •be 18 Years and older
- •cancer patients belonging to Veneto 's Oncological Network
- •Patients with SAR COV-2 infection
排除标准
- •Patients with no SAR COV2 Infection
- •Volunteers
- •No Cancer Patients
结局指标
主要结局
The rate of SAR-COV2 infection development in association with tumor characteristics.
时间窗: through study completion, an average of 18 months.
次要结局
未报告次要终点